Conservative management of intermittent claudication

Area of Science:

• Vascular Medicine
• Evidence-Based Medicine
• Interventional Cardiology

Background:

• Intermittent claudication (IC) is a common manifestation of peripheral arterial disease (PAD).
• Effective management of IC is crucial for improving patient mobility and quality of life.
• Contemporary treatments include pharmacotherapy (pentoxifylline), exercise, and smoking cessation.

Purpose of the Study:

• To systematically review and synthesize the evidence for the efficacy of three key treatments for intermittent claudication.
• To evaluate pentoxifylline, structured exercise programs, and smoking cessation interventions.

Main Methods:

• Comprehensive literature search of English-language studies using MEDLINE and Index Medicus.
• Inclusion of randomized controlled trials for pentoxifylline and controlled trials for exercise.
• Selection of 26 pertinent studies for smoking cessation after an exhaustive search; meta-analytic techniques used for efficacy estimation.

Main Results:

• Data quality for pentoxifylline was insufficient for a reliable efficacy estimate.
• Dynamic exercise therapy demonstrated a significant benefit in increasing pain-free walking distance (pooled effect size = 1.03).
• Smoking cessation was linked to reduced disease complications and enhanced postoperative graft patency.

Conclusions:

• The efficacy of pentoxifylline for intermittent claudication remains uncertain due to limited and low-quality data.
• Structured exercise programs are effective in improving pain-free walking distance in patients with IC.
• Smoking cessation is a vital intervention for reducing complications and improving vascular surgery outcomes in PAD patients.